Related provisions for SUP App 3.3.8
- (1)
Before a pure protection contract is concluded, a firm must inform a customer of the information in the table below.
- (2)
The information must be communicated in a clear and accurate manner, in writing, and in an official language of the State of the commitment or in another language agreed by the parties.
Information to be communicated before conclusion |
|
(1) |
The name of the insurance undertaking and its legal form. |
(2) |
The name of the EEA State in which the head office and, where appropriate, the agency or branch concluding the contract is situated. |
(3) |
The address of the head office and, where appropriate, of the agency or branch concluding the contract. |
(4)* |
Definition of each benefit and each option. |
(5)* |
Term of the contract. |
(6)* |
Means of terminating the contract. |
(7)* |
Means of payment of premiums and duration of payments. |
(8)* |
Information on the premiums for each benefit, both main benefits and supplementary benefits, where appropriate. |
(9) |
Arrangements for application of the cancellation period. |
(10) |
General information on the tax arrangements applicable to the type of policy. |
(11) |
The arrangements for handling complaints concerning contracts by policyholders, lives assured or beneficiaries under contracts including, where appropriate, the existence of a complaints body (usually the Financial Ombudsman Service), without prejudice to the right to take legal proceedings. |
(12) |
The law applicable to the contract where the parties do not have a free choice or, where the parties are free to choose the law applicable, the law the insurance undertaking proposes to choose. |
Note: The rule on mid-term changes applies to items marked with an asterisk (see ICOBS 6.3.3 R). |
[Note: Annex III(A) to the Consolidated Life Directive]
Sections 87H and 87I of the Act provide:
Prospectus approved in another EEA State |
|||
87H |
(1) |
A prospectus approved by the competent authority of an EEA State other than the United Kingdom is not an approved prospectus for the purposes of section 85 unless that authority has provided the competent authority with – |
|
(a) |
a certificate of approval; |
||
(b) |
a copy of the prospectus as approved; and |
||
(c) |
if requested by the [FSA], a translation of the summary of the prospectus. |
||
(2) |
A document is not a certificate of approval unless it states that the prospectus – |
||
(a) |
has been drawn up in accordance with the prospectus directive; and |
||
(b) |
has been approved, in accordance with that directive, by the competent authority providing the certificate. |
||
(3) |
A document is not a certificate of approval unless it states whether (and, if so, why) the competent authority providing it authorised, in accordance with the prospectus directive, the omission from the prospectus of information which would otherwise have been required to be included. |
||
(4) |
“Prospectus” includes a supplementary prospectus. |
Provision of information to host Member State |
|||
87I |
(1) |
The [FSA] must, if requested to do so, supply the competent authority of a specified EEA State with – |
|
(a) |
a certificate of approval; |
||
(b) |
a copy of the specified prospectus (as approved by the [FSA]); and |
||
(c) |
a translation of the summary of the specified prospectus (if the request states that one has been requested by the other competent authority). |
||
(2) |
Only the following may make a request under this section – |
||
(a) |
the issuer of the transferable securities to which the specified prospectus relates; |
||
(b) |
a person who wishes to offer the transferable securities to which the specified prospectus relates to the public in an EEA State other than (or as well as) the United Kingdom; |
||
(c) |
a person requesting the admission of the transferable securities to which the specified prospectus relates to a regulated market situated or operating in an EEA State other than (or as well as) the United Kingdom. |
||
(3) |
A certificate of approval must state that the prospectus – |
||
(a) |
has been drawn up in accordance with this Part and the prospectus directive; and |
||
(b) |
has been approved, in accordance with those provisions, by the [FSA]. |
||
(4) |
A certificate of approval must state whether (and, if so, why) the [FSA] authorised, in accordance with section 87B, the omission from the prospectus of information which would otherwise have been required to be included. |
||
(5) |
The [FSA] must comply with a request under this section – |
||
(a) |
if the prospectus has been approved before the request is made, within 3 working days beginning with the date of the request; or |
||
(b) |
if the request is submitted with an application for the approval of the prospectus, on the first working day after the date on which it approves the prospectus. |
||
(6) |
“Prospectus” includes a supplementary prospectus. |
||
(7) |
“Specified” means specified in a request made for the purposes of this section. |